265 related articles for article (PubMed ID: 27077959)
21. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.
Laatikainen R; Koskenpato J; Hongisto SM; Loponen J; Poussa T; Hillilä M; Korpela R
Aliment Pharmacol Ther; 2016 Sep; 44(5):460-70. PubMed ID: 27417338
[TBL] [Abstract][Full Text] [Related]
22. Microbiome, Metabolome and Inflammatory Bowel Disease.
Ahmed I; Roy BC; Khan SA; Septer S; Umar S
Microorganisms; 2016 Jun; 4(2):. PubMed ID: 27681914
[TBL] [Abstract][Full Text] [Related]
23. Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn's disease: an observational study.
Walton C; Montoya MP; Fowler DP; Turner C; Jia W; Whitehead RN; Griffiths L; Waring RH; Ramsden DB; Cole JA; Cauchi M; Bessant C; Naylor SJ; Hunter JO
Eur J Clin Nutr; 2016 Sep; 70(9):1052-6. PubMed ID: 27167669
[TBL] [Abstract][Full Text] [Related]
24. Nutritional, microbiological and psychosocial implications of the low FODMAP diet.
Staudacher HM
J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():16-19. PubMed ID: 28244658
[TBL] [Abstract][Full Text] [Related]
25. Low FODMAP diet efficacy in IBS patients-what is the evidence and what else do we need to know?
Kortlever T; Hebblethwaite C; Leeper J; O'Brien L; Mulder C; Gearry RB
N Z Med J; 2016 Sep; 129(1442):75-83. PubMed ID: 27657161
[TBL] [Abstract][Full Text] [Related]
26. The influence of a short-term gluten-free diet on the human gut microbiome.
Bonder MJ; Tigchelaar EF; Cai X; Trynka G; Cenit MC; Hrdlickova B; Zhong H; Vatanen T; Gevers D; Wijmenga C; Wang Y; Zhernakova A
Genome Med; 2016 Apr; 8(1):45. PubMed ID: 27102333
[TBL] [Abstract][Full Text] [Related]
27. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial.
Cox SR; Prince AC; Myers CE; Irving PM; Lindsay JO; Lomer MC; Whelan K
J Crohns Colitis; 2017 Dec; 11(12):1420-1429. PubMed ID: 28525543
[TBL] [Abstract][Full Text] [Related]
28. The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?
Gibson PR
J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():32-35. PubMed ID: 28244668
[TBL] [Abstract][Full Text] [Related]
29. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
[TBL] [Abstract][Full Text] [Related]
30. Managing irritable bowel syndrome: The low-FODMAP diet.
Dugum M; Barco K; Garg S
Cleve Clin J Med; 2016 Sep; 83(9):655-62. PubMed ID: 27618353
[TBL] [Abstract][Full Text] [Related]
31. Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: a pilot randomized trial.
Balfegó M; Canivell S; Hanzu FA; Sala-Vila A; Martínez-Medina M; Murillo S; Mur T; Ruano EG; Linares F; Porras N; Valladares S; Fontalba M; Roura E; Novials A; Hernández C; Aranda G; Sisó-Almirall A; Rojo-Martínez G; Simó R; Gomis R
Lipids Health Dis; 2016 Apr; 15():78. PubMed ID: 27090218
[TBL] [Abstract][Full Text] [Related]
32. Association between Polycystic Ovary Syndrome and Gut Microbiota.
Guo Y; Qi Y; Yang X; Zhao L; Wen S; Liu Y; Tang L
PLoS One; 2016; 11(4):e0153196. PubMed ID: 27093642
[TBL] [Abstract][Full Text] [Related]
33. Mucosa-attached bacterial community in Crohn's disease coheres with the clinical disease activity index.
Schäffler H; Herlemann DPR; Alberts C; Kaschitzki A; Bodammer P; Bannert K; Köller T; Warnke P; Kreikemeyer B; Lamprecht G
Environ Microbiol Rep; 2016 Oct; 8(5):614-621. PubMed ID: 27083382
[TBL] [Abstract][Full Text] [Related]
34. Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of Salmonella.
Rivera-Chávez F; Zhang LF; Faber F; Lopez CA; Byndloss MX; Olsan EE; Xu G; Velazquez EM; Lebrilla CB; Winter SE; Bäumler AJ
Cell Host Microbe; 2016 Apr; 19(4):443-54. PubMed ID: 27078066
[TBL] [Abstract][Full Text] [Related]
35. The Low FODMAP Diet: Many Question Marks for a Catchy Acronym.
Catassi G; Lionetti E; Gatti S; Catassi C
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28300773
[TBL] [Abstract][Full Text] [Related]
36. Age-mediated changes in the gastrointestinal tract.
Merchant HA; Liu F; Orlu Gul M; Basit AW
Int J Pharm; 2016 Oct; 512(2):382-395. PubMed ID: 27085646
[TBL] [Abstract][Full Text] [Related]
37. How to institute the low-FODMAP diet.
Barrett JS
J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():8-10. PubMed ID: 28244669
[TBL] [Abstract][Full Text] [Related]
38. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
Lewis JD; Abreu MT
Gastroenterology; 2017 Feb; 152(2):398-414.e6. PubMed ID: 27793606
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory Bowel Diseases and Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols: An Overview.
Barbalho SM; Goulart RA; Aranão ALC; de Oliveira PGC
J Med Food; 2018 Jul; 21(7):633-640. PubMed ID: 29328869
[TBL] [Abstract][Full Text] [Related]
40. Low FODMAP in 2017: Lessons learned from clinical trials and mechanistic studies.
Eswaran S
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 28345807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
